JI Jie-ying, GUO A-xia, ZHANG Wei-wei. Study of Maxing Tiaofei Tang in Reatment of Chronic Obstructive Pulmonary Disease by Inhibiting Inflammatory Reactions[J]. Chinese journal of experimental traditional medical formulae, 2016, 22(20): 127-131.
JI Jie-ying, GUO A-xia, ZHANG Wei-wei. Study of Maxing Tiaofei Tang in Reatment of Chronic Obstructive Pulmonary Disease by Inhibiting Inflammatory Reactions[J]. Chinese journal of experimental traditional medical formulae, 2016, 22(20): 127-131. DOI: 10.13422/j.cnki.syfjx.2016200127.
Objective: To discuss the therapeutic effect of Maxing Tiaofei Tang for chronic obstructive pulmonary disease(COPD) and explore its action mechanism. Method: The models of COPD rats were established by smoking exposure combined with intratracheal injection of lipopolysaccharide(0.1 mL). These SD rats were randomly divided into normal group
n=10 in each group. The drugs were administered 7 days after wound healing for 5 weeks. The levels of tumor necrosis factor-α(TNF-α)
nuclear factor-κB(NF-κB)
interleukin-1β(IL-1β)
IL-8 and IL-10 in serum were detected by ELISA; pulmonary functions and pathological changes were observed. Result: As compared with the normal group
the levels of TNF-α
NF-κB
IL-1β and IL-8 were significantly increased in model group; the level of IL-10 was significantly decreased(P<0.01); the lesions in pulmonary tissues were obvious; pulmonary functions were significantly decreased. As compared with the model group
Maxing Tiaofei Tang high-dose group could reduce the levels of TNF-α
NF-κB
IL-1β and IL-8
and increase the level of IL-10 in serum of the COPD rats(P<0.05
P<0.01); reduce the degree of pathological changes in lung tissues and improve the pulmonary functions. Conclusion: The mechanism of Maxing Tiaofei Tang for the COPD rats may be associated with regulating the levels in TNF-α